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Abstract
Introduction
Frozen shoulder is a common, fibro-proliferative disease characterised by the insidious
onset of pain and progressively restricted range of shoulder movement.
Despite the prevalence of this disease, there is limited understanding of the molecular
mechanisms underpinning the pathogenesis of this debilitating disease. Previous studies
have identified increased myofibroblast differentiation and proliferation, immune cell influx
and dysregulated cytokine production. We hypothesised that subpopulations within the
fibroblast compartment may take on an activated phenotype, thus initiating the inflammatory
processes observed in frozen shoulder. Therefore, we sought to evaluate the presence and
possible pathogenic role of known stromal activation proteins in Frozen shoulder,
Methods
Shoulder capsule samples were collected from 10 patients with idiopathic frozen shoulder
and 10 patients undergoing shoulder stabilisation surgery. Fibroblast activation marker
expression (CD248, CD146, VCAM and PDPN, FAP) was quantified using immunohis-
tochemistry. Control and diseased fibroblasts were cultured for in vitro studies from capsule
biopsies from instability and frozen shoulder surgeries, respectively. The inflammatory pro-
file and effects of IL-1β upon diseased and control fibroblasts was assessed using ELISA,
immunohistochemistry and qPCR.
Results
Immunohistochemistry demonstrated increased expression of fibroblast activation markers
CD248, CD146, VCAM and PDPN in the frozen shoulder group compared with control (p <
0.05). Fibroblasts cultured from diseased capsule produced elevated levels of inflammatory
protein (IL-6, IL-8 & CCL-20) in comparison to control fibroblasts. Exposing control fibro-
blasts to an inflammatory stimuli, (IL-1ß) significantly increased stromal activation marker
transcript and protein expression (CD248, PDPN and VCAM).
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Conclusions
These results show that fibroblasts have an activated phenotype in frozen shoulder and this
is associated with inflammatory cytokine dysregulation. Furthermore, it supports the hypoth-
esis that activated fibroblasts may be involved in regulating the inflammatory and fibrotic
processes involved in this disease.
Introduction
The fibroproliferative disorder, frozen shoulder is a multifactorial disease in which patients
present with limited active and passive shoulder movement[1]. Despite a prevalence of 2–5%
and known risk factors including diabetes, thyroid disease, stroke and autoimmune diseases
there remains a significant lack of understanding of the molecular mechanisms underpinning
this common fibrotic disorder which affects many recreational sporting individuals[2].
Recent studies have demonstrated altered expression of immune cells, inflammatory media-
tors and fibrosis associated cytokines in frozen shoulder. Chronic inflammatory cells including
mast cells, T and B cells and macrophages have been identified in shoulder capsule biopsies
from patients with frozen shoulder[3] while diseased capsule showed dysregulated cytokines
such as IL-1β, IL-6 and TNF-α, which are known to drive inflammatory/matrix interactions
[4] including fibroblast activation and dysregulated collagen synthesis. Additionally, we have
shown the cytokines interleukin 33 (IL-33) as an alarmin in early tendinopathy[5] whereby
when released from the resident tenocyte has the ability to modulate inflammatory/matrix
crosstalk and thus is likely to be important in the balance between reparation and degeneration
in tissue repair. Subsequently we discovered increased levels of the alarmins IL33 and high-
mobility group protein B1 (HMGB1)[6], which are known to not only initiate but amplify and
sustain the inflammatory processes in frozen shoulder. This reinforces the concept of immune
involvement in triggering, regulating and remission of inflammation in frozen shoulder[7].
Pathological shoulder capsule tissue has demonstrated myofibroblast differentiation and
proliferation in dense types I and III collagen matrix. Capsular fibrosis and contracture have
been suggested to stiffen the shoulder capsule and thus restrict range of motion[8] similar to
that in other fibrotic diseases such as Dupuytren’s disease. Fibroblasts are primarily responsi-
ble for the synthesis and remodelling of extracellular matrix and therefore tissue remodelling
and repair[9]. Increasingly, activation or impaired fibroblast function has been associated with
chronic inflammatory diseases such as RA[10] and soft tissue diseases such as tendinopathy
[10]. In normal circumstances fibroblasts act a sentinel like cells within tissue and are the first
to respond to danger/damage signals[11]. Activated/damaged fibroblasts in healing tissues or
inflamed can promote the recruitment and retention of immune cells as well as regulating
their behaviour[12]. Pathogenic activated fibroblasts have previously been identified in RA,
these were characterised by increased expression of podoplanin (PDPN), CD106 (VCAM-1)
and CD248 (tumour endothelial marker-1/endosialin) [13]. PDPN is a transmembrane glyco-
protein implicated in the invasiveness of cancer metastasis[14] and VCAM-1 functions as a
cell adhesion molecule[15]. CD248 is a transmembrane receptor with ligands that include col-
lagen 1 [16] and is up-regulated by inflammation and fibrosis while CD146 (M-CAM) is a cell
adhesion molecule that has been demonstrated to appear on a small subset of T and B lympho-
cytes in the peripheral blood of healthy individuals[17]. These fibroblast activation markers
have been identified in different locations of the synovium in rheumatoid arthritis[10] and soft
tissue tendinopathy[18]. In the tendon, inflammation induced fibroblast activation which was
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more profound in diseased compared to healthy tendon cells. The authors suggest persistent
fibroblast activation is an important mechanism for the development of chronic inflammation
in soft tissue musculoskeletal conditions drawing parallels with frozen shoulder.
We therefore hypothesised that subpopulations within the fibroblast compartment might
become activated and expanded during the inflammatory processes occurring in frozen shoul-
der. We designed a study to investigate whether fibroblast activation markers might contribute
to the pathogenic mechanisms of frozen shoulder and co-exist with inflammatory cytokines.
The aims of this study were to evaluate fibroblast activation in patients presenting with frozen
shoulder in an attempt to understand their association with this disease.
Materials and methods
Study design
A prospective case-control study was conducted at the Institute of Infection, Immunity and
Inflammation at the University of Glasgow, Scotland, UK and Department of Orthopaedic
Surgery, NHS Greater Glasgow and Clyde. The study was conducted in accordance with ethics
approval from Human Research Ethics Committee–West of Scotland REC (REC14/WS/1035)
with written informed consent obtained and carried out in accordance with standard operative
procedures.
Inclusion and exclusion criteria
The study included patients with primary frozen shoulders who were receiving arthroscopic
capsular releases. It also included patients with unstable shoulders undergoing arthroscopic
stabilization as control groups as these patients were thought not to have their primary shoul-
der disease affecting the shoulder capsule and required glenohumeral arthroscopy, which was
necessary to obtain tissue samples.
The diagnosis of frozen shoulder was made using Codman’s modified criteria by Zucker-
man and Rokito[1]. The inclusion criteria for the frozen shoulder population comprised a
painful stiff shoulder with insidious onset, restricted elevation to�100˚, passive external rota-
tion�50% of the normal contralateral shoulder, loss of function of the affected arm, pain at
night and inability to lie on the affected side, and unremarkable radiographic and ultrasound
findings of the glenohumeral joint. The exclusion criteria included history of previous surgery
of the involved shoulder and radiologic or arthroscopic signs of fracture, glenohumeral arthri-
tis, history of shoulder trauma and concomitant rotator cuff tear.
Sample collection
Tissue specimens were excised from the shoulder capsule by four different shoulder surgeons
(NLM,DM,AA,UGF) during glenohumeral joint arthroscopy in patients undergoing either
arthroscopic capsular release, stabilization or subacromial decompression surgery as previ-
ously described[19]. The tissue was removed by meniscal basket forceps from the shoulder
capsule of the rotator interval. The biopsied tissue was immediately fixed in 10% buffered for-
malin for 18 to 24 hours, dehydrated, and embedded in paraffin wax.
Immunohistochemistry
Samples for immunohistochemistry were immediately fixed in 10% formalin solution and
stained with haematoxylin and eosin. Ten unstained sections were immunostained for the
fibroblast activation markers CD248 (HPA051856 Rabbit 1:200), CD146 (HPA008848 Rabbit
1:500), CD90 (HPA003733 Rabbit 1:500), PDPN (HPA007534 Rabbit 1:1000), CD34
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(HPA036722 Rabbit 1:200), FAP (HPA059739 Rabbit 1:500) and VCAM-1 (HPA034796 Rab-
bit 1:200 (all Sigma-Aldrich). Equivalent sections were also stained using the relevant isotype
control to confirm positive staining of antibodies. The unstained sections were de-waxed in an
oven at 60˚C for 35 minutes. They were then immersed in 2 changes of xylene for 5 minutes
each, and deparaffinated in 100%, 90% and 70% ethanol solution for 3 minutes of 2 cycles,
thereafter they were rehydrated in distilled water for 5 minutes. Sections were then immersed
in 0.5% hydrogen peroxide made up in methanol for 30 minutes to block endogenous peroxi-
dase activity and then Tris Buffered Saline 0.05% Tween (TBST) solution (pH7.6). Endogenous
peroxidase activity was quenched with 3% (v/v) H2O2, and nonspecific antibody binding
blocked with 2.5% horse serum in TBST buffer for 30 minutes. Antigen retrieval was per-
formed in 0.01M citrate buffer for 20 minutes in a microwave. The sections were left overnight
to incubate at 4˚C.
The sections were brought to room temperature for 30 minutes, and washed in TBST solu-
tion for 5 minutes. The sections were then incubated in DAB solution (1 drop DAB to 1ml
DAB diluent) for 30 seconds, and quickly washed with TBST solution. They were then dipped
twice in haematoxylin, washed in water, dipped in Scott solution to blue and then dehydrated
in 70% ethanol, 90% ethanol for 30 seconds,1 minute respectively, and 2 changes of 3 minutes
in 100% ethanol. Then they were cleared in 2 changes of xylene for 3 minutes and mounted in
DPX with a coverslip.
Immunostaining of cells was conducted in 8 well chamber slides by fixing the cells in 100%
methanol for 5 minutes. Cells were rinsed with PBS and nonspecific antibody binding blocked
with 2.5% horse serum in TBST buffer for 30 minutes. Cells were stained overnight at 4˚C
with the appropriate antibody/isotype. Following this, slides were washes with TBST incubated
with DAB and dehydrated as described above. The slides were then mounted in DPX with a
coverlip.
Cell culture and treatments
Control and diseased fibroblasts were explanted form capsule biopsies undergoing surgery as
described above. Patients ranged from 18–30 (Table 1) undergoing elective arthroscopic stabi-
lisation surgery. Cultures were maintained in a humidified environment at 37˚C, 5% CO2 in
RPMI 1640 supplemented with 10% heat-inactivated Fetal Bovine Serum (FBS), 100U/ml pen-
icillin, 100μg/ml streptomycin and 2nM L-glutamine (all Thermo Fisher Scientific). Cells were
grown to subconfluency and passaged using trypsin-EDTA (Sigma-Aldrich). Fibroblasts from
the second and third passage were seeded two days prior to stimulation.
Table 1. Patient demographics.
Adhesive Capsulitis Control Capsule
No. of Patients 10 10
Mean Age (years) 52 (40–63) 24 (18–30)
Gender (F:M) 7:3 3:7
Duration of symptoms (months) 6.3 ± 3 3.9 ± 2
Range of motion (degrees)
Forward flexion
80 ± 12 160 ± 8
Abduction 62 ± 10 145 ± 10
External Rotation 11 ± 5 60 ± 15
Mean number of steroid injections prior to surgery 2.2± 0.2 0.8± 0.1
https://doi.org/10.1371/journal.pone.0215301.t001
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Fibroblasts were seeded at 2.5 x104/ml in 24 well culture plates and allowed to rest for 48
hours. Fibroblasts were then stimulated with 10ng/ml recombinant human IL-1β (Biolegend)
for 24 hours in complete RPMI.
Microscopic analysis
Tissue sections were examined under light microscopy at x10 and x40 magnifications and
compared to the isotype controls. Representative photomicrographs of the sections in each
group were made. Two experienced examiners (JHR, NLM) blinded to the identity of the
stained sections, performed the counting of each section.
Tissue analysis occurred in two stages: the first stage had all samples being given a semi-
quantitative grade based on the percentage of positively-stained cells (taken over the total
number of cells in that field) in 10 random high-powered fields. The following semi-quantita-
tive grading was used: Grade 0, no staining, Grade 1, mild,�10% of cells stained positive;
Grade 2, moderate, 10% to 20% of cells stained positive, Grade 3, strong,�20% of cells stained
positive. The mean of these values was analysed by an unpaired Student’s t-test.
In the second stage, the samples had 10 random high-powered fields analysed at x40 magni-
fication, and cells in each field were counted manually. The mean percentage of positively
stained cells was taken over the total number of cells per high powered field, similarly, the
results were analysed by an unpaired Student’s t-test.
RNA extraction, cDNA synthesis and real time qPCR
Cells were placed in lysis buffer containing 1% 2-mercaptoethanol and RNA was extracted
using mini columns according to the manufacturer’s instructions. RNA concentration and
purity was determined using a spectrophotometer (Nanodrop 2000, Invitrogen). 100ng of
RNA was converted to cDNA using High Capacity cDNA reverse transcription kit (Invitro-
gen) according to manufacturer’s instructions. cDNA was diluted 1 in 5 using RNase free
water. qPCR was performed using PowerUp Sybr Green Mastermix (Invitrogen) and 1μl
cDNA was used per reaction with 0.1μM of forward and reverse primers. Each sample was run
in duplicate and normalized to GAPDH or 18S endogenous control. Data represents fold
change from untreated cells (2-ΔΔCT).
Primers (Integrated DNA Technologies) were as follows:
GAPDH (f) 50-TCGACAGTCAGCCGCATCTTCTTT-30
(r) 50-ACCAAATCCGTTGACTCCGA CCTT-30
CD248 (f) 50- CCCAAATCCCAAGGGAAGAT-30
(r) 50- CTGTGCTCGGCAAGACC-30
MCAM (f) 50- CGGCACGGCAAGTGAAC -30
(r) 50- GCATTCAACACCTGTCTCCAAC-30
PDPN (f) 50- CTTGACAACTCTGGTGGCA-30
(r) 50- GCGCTTGGACTTTGTTCTTG-30
VCAM (f) 50- GCAAGTCTACATATCACCCAAGA-30
(r) 50- TAGACCCTCGCTGGAACA-30
IL-6 (f) 50- CAC TCA CCT CAG AAC GAA -30
(r) 50- GCT GCT TTC ACA CAT GTT ACT -30
IL-8 (f) 50- GTG CAT AAA GAC ATA CDC CAA ACC -30
(r) 50- GCT TTA CAA TAA TTT CTG TGT TGG -30
CCL20 (f) 50- GTC TTG GAT ACA CAG ACC GTA TT -30
(r) 50- GTG TGA AAG ATG ATA GCA TTG ATG T -30
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Measurement of cytokine release by ELISA
Cell culture supernatants were collected and the concentrations of IL-6, IL-8 (both Invitrogen)
and CCL20 (Biolegend) were determined using commercially available ELISA kits. Optical
density was measured at 450 nm by a microplate reader.
Statistical analysis
Results are reported as the mean value and the standard error of mean. Comparisons between
groups were made with two-way paired Student t-tests, Mann-Whitney U tests, and Kruskal-
Wallis one-way analysis of variance on ranks. Based on our previous immunohistochemical
studies[20] and power calculations[21, 22] (power of 0.8 and beta error of 0.2), we identified
that each group required ten patient samples to detect a 20% difference in immunostaining for
the various activation markers.
Results
Demographics
Shoulder capsule of a total of 20 patients were included in the study. Of these 20 patients, 10
had adhesive capsulitis (7 female, 3 male) with a mean age of 52 (range, 40–63 years) and 10
control subjects (shoulder instability, supraspinatus tendinopathy) (3 female, 7 male) with a
mean age of 31 (range, 16–46 years). The control group was significantly younger than adhe-
sive capsulitis group (p<0.01). The mean number of glenohumeral joint injections was signifi-
cantly (p<0.05) greater in the frozen shoulder group compared to control (Table 1).
Pain and stiffness scores
Patient-ranked pain frequency (p = 0.01), pain severity (p = 0.03) and stiffness (p = 0.03) were
significantly higher in the frozen shoulder group compared to the instability group (Fig 1).
Shoulder motion was also significantly more restricted in external rotation, internal rotation,
forward flexion and abduction in frozen shoulder patients compared to control group (Fig 1).
Histologic appearance of the shoulder capsule
The histologic appearance of the H&E-stained frozen shoulder capsule specimens showed
densely packed collagen fibres and fibroblastic proliferation within the fibrous compartment
compared with the control (Fig 2). There were large numbers of capillaries and venules in the
subsynovium of frozen shoulder samples compared with the controls. Capsule specimens
from 5 control patients (3 instability, 2 supraspinatus tendinopathy) also exhibited few
capillaries and venules in the subsynovium whereas 4 (3 instability, 1 supraspinatus tendinopa-
thy) had increased vascularity.
Diseased capsule tissues express fibroblast activation markers
There was significantly greater expression of the activation markers, CD248, CD146, VCAM
and PDPN in the frozen shoulder group compared with the control group (p< 0.05) (Figs 1 &
2). CD248 and VCAM were mainly localised to fibroblast-like cells (Fig 1) however, whilst
exhibiting a similar pattern, PDPN also showed significant extracellular matrix staining pat-
tern. Further sub analysis of tissue distribution revealed that PDPN was most abundantly
expressed in adhesive capsulitis with approximately 60% of cells positive versus 40% in control
tissues (Fig 2) followed by CD248 (60% versus 25% control, p<0.01) and VCAM (20% versus
5% control, p<0.01). CD146 was more positively stained in frozen shoulder tissue sections
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than control capsule tissue (25% versus 18% control, p<0.05). However, some of the CD146
staining was around the increased vasculature described above. We found no differential
expression of CD34 nor FAP between normal of diseased tissue samples.
Fig 1. Fibroblast activation markers in shoulder capsule. Representative images of and control capsule and frozen
shoulder tissue sections stained with Haematoxylin and Eosin (x10 magnification, bar indicates 200μm) and antibodies
against CD248, CD146, VCAM, PDPN, CD34, and FAP (x40). Isotype control in bottom right corner (x10
magnification, bar indicates 150μm).
https://doi.org/10.1371/journal.pone.0215301.g001
Fig 2. Fibroblast activation marker expression in control capsule and frozen shoulder. Graphs illustrate Modified
Bonar scoring & % of cells positively stained for samples of human capsule biopsies for expression of CD248, CD146,
VCAM, PDPN, CD34 and FAP, mean ± SEM, n = 10 for control capsule, n = 10 for frozen shoulder capsule.
Modified Bonar scoring system depicts mean score per sample based on 10 high power fields. 0 = no staining, 1 = <
10%, 2 = 10–20%, 3 = >20% + ve staining of cells per high power field. �p< 0.05, ��p< 0.01 (Students t-test).
https://doi.org/10.1371/journal.pone.0215301.g002
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Inflammatory cytokines are overexpressed in diseased versus normal
capsular cells
To understand if the presence of fibroblast activation markers was associated with an inflam-
matory signature within frozen shoulder fibroblasts we analysed the gene expression of inflam-
matory associated cytokines/chemokines. We found that fibroblasts cultured from diseased
capsule produced greater levels of inflammatory proteins compared to cells cultured from con-
trol capsule, in standard culture condition with no inflammatory stimuli (Fig 3). This was the
case for the cytokines IL-6 and IL-8, as well as the chemokine CCL20.
Inflammation induces persistent fibroblast activation in control cells
Having identified that stromal fibroblast activation markers were expressed at higher level in
diseased capsular tissues and stromal cells cultured from these tissues secreted more inflamma-
tory proteins we sought to investigate whether an inflammatory stimuli (IL-1β) could induce
fibroblast “memory” in healthy cells in vitro. Fig 4 demonstrates that healthy fibroblasts had
increased CD248, PDPN and VCAM mRNA expression compared to unstimulated cells
(p<0.05). Furthermore, IL-1β treatment for 24 hours also induced CD248, PDPN VCAM and
CD146 protein expression in healthy capsule cells (Fig 4). To ascertain whether this inflamma-
tory simulated “diseased phenotype” fibroblast had any functional relevance we measure the
inflammatory proteins released into the supernatant. We found control fibroblasts following
inflammatory stimuli significantly increased mRNA expression and protein secretion of IL-6,
IL-8 and CCL20 (Fig 5).
Discussion
This study is the first to investigate the difference in expression of fibroblast activation in cap-
sule tissue from control and adhesive capsulitis patients. We have demonstrated the presence
of CD248, CD146, VCAM, PDPN, CD34 and FAP in shoulder capsule tissue of patients with
frozen shoulder co existing with proinflammatory cytokine expression. Importantly inflamma-
tory activation of healthy fibroblasts leads to overexpression of fibroblast activation markers in
addition to secreting inflammatory proteins suggesting this may drive disease chronicity as
illustrated in Fig 6.
Increasingly datasets from human biopsy studies in patients with frozen shoulder have sug-
gested a strong immune component to the underlying disease process[2]. Histologically, fro-
zen shoulder tissue is characterized by fibroblasts, myofibroblasts and chronic inflammatory
cells, including mast cell, T-cells, B-cells and macrophages[23, 24]. Furthermore cytokines
such as IL-1β, IL-6 and TNF-α, which are known to drive inflammatory/matrix interactions
[4] including fibroblast activation and dysregulated collagen synthesis are upregulated in
Fig 3. Inflammatory cytokine production from capsule derived fibroblasts. IL-6, CCL20 and IL-8 secretion from
healthy capsule and diseased capsule derived fibroblasts, mean ± SEM, n = 5 �p< 0.05 (Students t-test).
https://doi.org/10.1371/journal.pone.0215301.g003
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adhesive capsulitis versus normal shoulder capsule[25] and the subacromial bursa[26] of fro-
zen shoulder patients. The most abundant cell type within tissue stroma remains the fibroblast
which play a central role in determining the site at which inflammation occurs, and influence
the persistence of the inflammatory process[27]. Once activated, fibroblasts have been shown
to produce TNFα, IL-1, and IL-6, cyclooxygenase-2, the polysaccharide hyaluronan, as well as
inflammatory chemokines[28] thus sustaining leukocyte recruitment in to the inflamed syno-
vium. Podoplanin (PDPN), a 38-kDa type I transmembrane glycoprotein which is found in
some fibroblasts, and an abundance of PDPN-positive fibroblasts is associated with poor prog-
nosis in lung adenocarcinoma, invasive breast cancer, and esophageal squamous cell carci-
noma patients[14]. Furthermore, PDPN expression can be upregulated by a number of pro-
inflammatory cytokines, including IL-22, IL-6, IFN-γ, TGF-β, IL-1β, and TNF-α, but the
Fig 4. Fibroblast activation markers are upregulated in shoulder capsule upon inflammatory stimulus and
inflammatory protein in healthy fibroblasts following IL-1β (10ng/ml) stimulation. (a) Stromal activation marker
(CD248, PDPN, VCAM & CD146) mRNA expression following IL-1β stimulation of cultured healthy derived
fibroblasts. Data represented 2-ΔΔCT, normalized to GAPDH housekeeping control, mean ± SEM, n = 5. �p< 0.05,
��p< 0.01 compared to control samples (Students t-test). (b) Representative images of healthy capsule derived
fibroblasts following IL-1β stimulation. Cells stained with antibodies against CD248, PDPN, VCAM and CD146,
image at x40 magnification (bar is 200μm). Isotype control in bottom left corner (x40).
https://doi.org/10.1371/journal.pone.0215301.g004
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signalling pathways involved are largely unknown. Given the previous finding that PDPN may
be a component of chronic soft tissue inflammation our results demonstrating significantly
increased PDPN in frozen shoulder suggest that the chronic inflammation changes may be
similar to those seen in tendinopathy. Further work is now required to dissect the role of podo-
planin in immune cell interactions within frozen shoulder and its role in driving a dysregu-
lated fibrotic tissue response.
VCAM-1 belongs to the Ig superfamily and is expressed on monocytes, endothelial cells
and synovial cells. In inflammatory reactions VCAM-1 is a surface glycoproteins that promote
adhesion and subsequent recruitment of leukocytes. The levels of circulating VCAM-1 in
plasma and synovial fluid both were significantly increased in rheumatoid arthritis patients
compared to normal controls[29]. VCAM-1 has also been shown to be upregulated following
damage associated protein (alarmin) release from epithelial cells. In a similar cohort of patients
we have recently reported elevation of the alarmins HMGB1 and IL-33 and S100A8/A9 in the
Fig 5. Activated capsule fibroblasts drive proinflammatory cytokine production. IL-6, CCL20 and IL-8 mRNA and
protein expression following IL-1β stimulation. mean ± SEM, n = 5, �p< 0.05, ��p< 0.01 compared to control
samples (Students t-test).
https://doi.org/10.1371/journal.pone.0215301.g005
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shoulder capsule of patients with frozen shoulder compared to controls while furthermore
confirming significantly increased neoinnervation linked to patient reported pain[6]. Thus,
given that activation of the immune system after tissue injury is partially due to the interac-
tions of alarmins released from necrotic cells and subsequent upregulation of fibroblast activa-
tion markers this association may represent an important synergy between fibroblast markers
and inflammatory molecules that can drive the disease chronicity and fibrosis associated with
frozen shoulder. Future work assessing associations between fibroblast markers and alarmin
molecules in patient subgroups may help address whether these interactions are linked to fail-
ure of appropriate tissue repair. Interestingly, agents targeting stromal biology have delivered
promising in vitro and in vivo data[30–32] particularly altering matrix regulation. This sug-
gests targeting fibroblast activation may offer novel therapeutic potential in frozen shoulder.
Whilst CD146 was upregulated in diseased tissue compared with control, some of this stain-
ing was concentrated around the increased vasculature observed in diseased tissue as this pro-
tein (along with CD34) is expressed by other stromal cells such as endothelial cells. However,
CD146 also stained positive around non-vasculature of adhesive capsulitis sections.
Fig 6. Immunobiology of frozen shoulder. Schematic illustration representing the functional interplay between the
“activated” stromal fibroblast (CD248+, CD146+,VCAM+,PDPN+) (stromal compartment), infiltrating and resident
immune cells (immune compartment) and downstream cytokine/alarmin dysregulation interacting to drive a
proinflammatory phenotype with aberrant tissue fibrosis in the frozen shoulder joint capsule.
https://doi.org/10.1371/journal.pone.0215301.g006
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Additionally, this protein was up regulated in stimulated control fibroblasts. The upregulation
of this adhesion molecule in the inflammatory state may be due result in greater cell migration
and differentiation observed in adhesive capsulitis.
In contrast to other fibroblast associated pathologies FAP and CD34 were expressed to the
same extent in frozen shoulder when compared to control capsule. FAP was initially identified
in the context of RA[33] with activated phagocytes expressing this protein in the inflammatory
lesions in synovium[34]. Thus, in frozen shoulder it appears that the FAP and CD34 may not
represent activation markers but constituently expressed surface proteins which may be
involved in homeostatic tissue responses. However, it is possible that these markers may be
linked to a degree of inflammation that may be induced by acute trauma in a destabilised joint,
hence we were unable to observe any significant difference between the control tissue and
disease.
There are limitations inherent in our study. The study had a small sample size however our
previous studies[19, 21, 35] and power analysis confirms that 10 patient samples per group
gives us confidence that the changes seen do represent a biologically relevant change in protein
expression. Additionally, there was selection bias in that we only studied patients with frozen
shoulder that warranted a surgical procedure and thus did not include asymptomatic patients
or patients with less pain intensity with frozen shoulder. Furthermore, the patients in the con-
trol group were younger, predominately male, and had shorter duration of symptoms com-
pared with the frozen shoulder group which is an unfortunate consequence of the availability
of human control tissues. Three surgeons were involved in the collection of samples, giving
rise to the possibility that surgical technique and biopsies had some user-related differences.
Despite this, the same method of obtaining samples was used in order to reduce the surgeon-
related bias. This study ensured that comparison only occurred between shoulder capsule sam-
ples of patients with adhesive capsulitis and shoulder capsules samples of patients with instabil-
ity. This allowed a comparison between the same type of tissue and removed the possibility
that pathology in other tissue types–such as tendons, could confound the study. The exclusion
of patients with concurrent pathologies such as osteoarthritis and rheumatoid arthritis also
allowed better isolation of cases to adhesive capsulitis in the shoulder. As such, results of
immunoreactivity were less likely to be affected by other comorbidities.
Conclusion
This original study, is the first to have shown that there is elevation of fibroblast activation
markers in the shoulder capsule of patients with frozen shoulder compared to control capsular
tissue while furthermore confirming significantly increased proinflammatory signalling within
frozen shoulder capsule. This data is consistent with the hypothesis that persistent fibroblast
activation may play a role in the pathology of frozen shoulder and could explain the cellular
mechanisms behind capsular fibrosis and persistent inflammation.
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